FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281702014> ?p ?o ?g. }

• W4281702014 abstract "Insulin and its secretagogues are essential for some patients with type 2 diabetes (T2D) to maintain glycemic control (GC) . However, these drugs are inevitably accompanied by hypoglycemia. Avoiding severe hypoglycemia (SH) is essential considering its poor prognosis. This network meta-analysis aimed to find optimal hypoglycemic treatment regimens for T2D in terms of GC and SH. MEDLINE and EMBASE were used to identify trials comparing 2 or more treatments including insulins and/or SU/glinide and included both GC and SH in study outcomes. Treatment hierarchy was summarized as the surface under cumulative ranking probabilities (SUCRA) . There were 137 eligible trials from which 36 treatments were identified. Insulin plus (+) non-insulin drugs except for SU/glinide (others) had a higher SUCRA for changes in hemoglobin A1c (A1C) compared with only insulins (68.2±5.6% vs. 39.9±6.6%; P=0.01) although the difference in the SUCRA for SH was not significant (P=0.59) . Compared with only insulins, SU/glinide + others had a lower SUCRA for SH (42.4±5.8% vs. 58.5±3.4%, P=0.05) and comparable SUCRA for A1C change (P=1.00) . Cluster analysis indicated that premixed insulin + glucagon-like peptide-1 receptor agonist (Mix-ins+GLP1) consistently belonged to the high-efficacy group for A1C change and achievement of A1C&lt;7.0% and ≤6.5% among the insulin + others therapies. Glinide + thiazolidinedione (TZD) was in groups with high efficacy in terms of A1C change and achievement of A1C&lt;7.0% and high safety regarding SH among SU/glinide + others therapies. Results suggest that in T2D patients adjunctive use of non-insulin drugs (particularly, Mix-ins+GLP1) are recommended for further improving GC and that appropriate combinations of non-insulin hypoglycemic agents (particularly, glinide+TZD) are recommended to avoid SH and extend the time to treatment failure of non-insulin therapy. Disclosure S.Kodama: None. K.Kato: None. K.Watanabe: None. H.Sone: Research Support; Astellas Pharma Inc., Eisai Co., Ltd., Kyowa Kirin Co., Ltd., Novo Nordisk, Ono Pharmaceutical Co., Ltd., Taisho Pharmaceutical Holdings Co., Ltd., Takeda Pharmaceutical Company Limited. T.Sato: None. M.H.Yamada: None. M.Yamamoto: None. Y.Matsubayashi: None. H.Ishiguro: None. M.Iwanaga: None. K.Fujihara: None. T.Yamada: None." @default.
• W4281702014 created "2022-06-13" @default.
• W4281702014 creator A5005728440 @default.
• W4281702014 creator A5007023852 @default.
• W4281702014 creator A5013214368 @default.
• W4281702014 creator A5026094017 @default.
• W4281702014 creator A5033934430 @default.
• W4281702014 creator A5042086791 @default.
• W4281702014 creator A5047981899 @default.
• W4281702014 creator A5062636448 @default.
• W4281702014 creator A5064581003 @default.
• W4281702014 creator A5072785004 @default.
• W4281702014 creator A5077353102 @default.
• W4281702014 creator A5087247896 @default.
• W4281702014 date "2022-06-01" @default.
• W4281702014 modified "2023-09-25" @default.
• W4281702014 title "378-P: Network Meta-analysis of Hypoglycemic Treatment Regimens with Potential Risk of Hypoglycemia in Terms of Glycemic Control and Severe Hypoglycemia" @default.
• W4281702014 doi "https://doi.org/10.2337/db22-378-p" @default.
• W4281702014 hasPublicationYear "2022" @default.
• W4281702014 type Work @default.
• W4281702014 citedByCount "0" @default.
• W4281702014 crossrefType "journal-article" @default.
• W4281702014 hasAuthorship W4281702014A5005728440 @default.
• W4281702014 hasAuthorship W4281702014A5007023852 @default.
• W4281702014 hasAuthorship W4281702014A5013214368 @default.
• W4281702014 hasAuthorship W4281702014A5026094017 @default.
• W4281702014 hasAuthorship W4281702014A5033934430 @default.
• W4281702014 hasAuthorship W4281702014A5042086791 @default.
• W4281702014 hasAuthorship W4281702014A5047981899 @default.
• W4281702014 hasAuthorship W4281702014A5062636448 @default.
• W4281702014 hasAuthorship W4281702014A5064581003 @default.
• W4281702014 hasAuthorship W4281702014A5072785004 @default.
• W4281702014 hasAuthorship W4281702014A5077353102 @default.
• W4281702014 hasAuthorship W4281702014A5087247896 @default.
• W4281702014 hasConcept C126322002 @default.
• W4281702014 hasConcept C134018914 @default.
• W4281702014 hasConcept C2777180221 @default.
• W4281702014 hasConcept C2778854520 @default.
• W4281702014 hasConcept C2779306644 @default.
• W4281702014 hasConcept C2780473172 @default.
• W4281702014 hasConcept C2780668416 @default.
• W4281702014 hasConcept C555293320 @default.
• W4281702014 hasConcept C71924100 @default.
• W4281702014 hasConceptScore W4281702014C126322002 @default.
• W4281702014 hasConceptScore W4281702014C134018914 @default.
• W4281702014 hasConceptScore W4281702014C2777180221 @default.
• W4281702014 hasConceptScore W4281702014C2778854520 @default.
• W4281702014 hasConceptScore W4281702014C2779306644 @default.
• W4281702014 hasConceptScore W4281702014C2780473172 @default.
• W4281702014 hasConceptScore W4281702014C2780668416 @default.
• W4281702014 hasConceptScore W4281702014C555293320 @default.
• W4281702014 hasConceptScore W4281702014C71924100 @default.
• W4281702014 hasIssue "Supplement_1" @default.
• W4281702014 hasLocation W42817020141 @default.
• W4281702014 hasOpenAccess W4281702014 @default.
• W4281702014 hasPrimaryLocation W42817020141 @default.
• W4281702014 hasRelatedWork W2045993936 @default.
• W4281702014 hasRelatedWork W2057434408 @default.
• W4281702014 hasRelatedWork W2068655959 @default.
• W4281702014 hasRelatedWork W2076754594 @default.
• W4281702014 hasRelatedWork W2083753940 @default.
• W4281702014 hasRelatedWork W2108456334 @default.
• W4281702014 hasRelatedWork W2110641431 @default.
• W4281702014 hasRelatedWork W2112253737 @default.
• W4281702014 hasRelatedWork W2121663374 @default.
• W4281702014 hasRelatedWork W2182635640 @default.
• W4281702014 hasVolume "71" @default.
• W4281702014 isParatext "false" @default.
• W4281702014 isRetracted "false" @default.
• W4281702014 workType "article" @default.